Michael Shetzline, SVP, CMO, Head-Res&Drug at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 82,538 shares at $1.76 ($145K) on 2025-02-10, disclosed to the SEC on 2025-02-12.
Open-market sale of $145k IRWD by SVP, CMO, Head-Res&Drug. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.76 | 41,269 | $73K | 50.0% |
| 2 | $1.76 | 41,269 | $73K | 50.0% |
| Total | $1.76 avg | 82,538 | $145K | 100% |
| Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |
| IRWD | SELL | 2023-03-01 | $385K | — | Filing → |